SVRASavara Inc.
What is the market doing?
The market is leaning against it: in a downtrend (−22% vs 200-day) and a crowded short (+21% of shares).
In a downtrend, below its 50- and 200-day averages. Price is −22% vs its 200-day average.
A crowded short, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How SVRA is trading
Savara Inc. is +18% over the past year while the S&P 500 is +16%: 1.6 points ahead of the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −22%
vs 200-day average · a clear downtrend
- RSI (14)
- 35
RSI (14) · neutral
- Below its 52-week high
- 39%
Below its 52-week high
Details›
- Last close2026-10-23
- $4.21
- 1 monthS&P 500 −0.94%
- −17%
- 1 yearS&P 500 +16%
- +18%
- 5 yearsS&P 500 +86%
- +219%
- vs 50-day average$5.13
- −18%
- 52-week high
- $6.94
- 52-week low
- $3.61
- Annualised volatility
- 62%
- Insider selling, net, 6 monthsForms 3/4/5 to 2026-10-22
- $2.2M
| Year | Return |
|---|---|
| 2026 (year to date) | −30% |
| 2025 | +96% |
| 2024 | −35% |
| 2023 | +203% |
| 2022 | +25% |
| 2021 | +7.8% |
| 2020 | −74% |
| 2019 | −41% |
| 2018 | −49% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 9 | 4 of 9 | +2.4% |
| Feb | 9 | 3 of 9 | −2.3% |
| Mar | 9 | 4 of 9 | −0.41% |
| Apr | 9 | 4 of 9 | +4.5% |
| May | 10 | 5 of 10 | −2.2% |
| Jun | 10 | 6 of 10 | +0.45% |
| Jul | 10 | 5 of 10 | −1.0% |
| Aug | 10 | 5 of 10 | −0.83% |
| Sep | 10 | 5 of 10 | +7.1% |
| Oct | 10 | 1 of 10 | −15% |
| Nov | 9 | 6 of 9 | +20% |
| Dec | 9 | 4 of 9 | +29% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.
Biotechnology
Ranks #100 of 194 by RyuScore